Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

myRocky vs RegenCen

myRocky
Graded #487

Lower grade

vs+8.399999999999999
RegenCen
Graded #334

Higher grade

The verdict

RegenCen takes it — 59.8/100 to 51.4/100.

RegenCen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RegenCen is a women's and menopause-focused practice offering its Medically Guided Weight Loss program with GLP-1 medications including semaglutide and tirzepatide, paired with peptides, metabolic care, and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRegenCen +11
34
45
Dose & formulationmyRocky +13
53
40
Clinical oversightRegenCen +16
64
80
Labs & monitoringRegenCen +33
52
85
FulfillmentmyRocky +8
70
62
Contract termsRegenCen +14
41
55
myRocky · left barRegenCen · right bar

The numbers

MetricmyRockyRegenCen
WeighScore51.4/10059.8/100
GradeCC
Scorecard rank#487#334
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published2 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)
RegenCen

Graded #334 · C

Strengths

  • Virtual consultations by video or phone for MI and FL patients
  • MD-led oversight (Dr. Gustav Lo) plus PA co-founder
  • Menopause Society Certified Practitioners on staff
  • GLP-1 paired with coaching and metabolic care
  • Bundles weight loss with bioidentical hormone therapy

Where it loses points

  • Telehealth limited to Michigan and Florida
  • No published GLP-1 medication pricing
  • No named pharmacy or medication sourcing details
  • Menopause/women's focus rather than weight-loss-only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard